Graham Capital Management, L.P. Precigen, Inc. Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Precigen, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 13,612 shares of PGEN stock, worth $26,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,612Holding current value
$26,679% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding PGEN
# of Institutions
148Shares Held
162MCall Options Held
150KPut Options Held
29.5K-
Third Security, LLC83.5MShares$164 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$35 Million1.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$21.3 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$20.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$16.3 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $408M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...